Magnetic resonance imaging use is increasing in routine preoperative evaluation of women with breast cancer
the ONA take:
A population-based retrospective cohort study was conducted to determine patterns in the utilization of preoperative breast magnetic resonance imaging (MRI) in a health care system with universal insurance.
Breast MRI is commonly used in preoperative evaluation of women with breast cancer despite the existing literature showing the practice has little benefit for most patients.
Using administrative heath care databases in Ontario, Canada, the study included 53,015 patients with primary operable breast cancer treated from 2003 to 2012 in more than 14 geographic regions.
Primary outcomes were defined as use of preoperative breast MRI by year, geographic region, and breast cancer stage. In addition, the researchers evaluated postdiagnosis imaging, biopsy, and short-term surgical outcomes between those who did and did not receive MRI.
The study results indicate that 14.8% of patients had a preoperative MRI, and its use increased across all stages by 8-fold. The researchers report that preoperative breast MRI is associated with a significant increase in ancillary investigations, wait time to surgery, mastectomies, and contralateral prophylactic mastectomies.
Study to determine patterns in the utilization of preoperative breast magnetic resonance imaging (MRI) in a health care system with universal insurance.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- High Symptom Burden With Polycythemia Vera Linked to QoL Impairment
- Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- MRD Negativity Associated With Prolonged Survival in Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Patient Navigation Reduces Delays in Diagnostic Resolution
- Fee-for-service Medicare Plans Linked to Improved Care During Last Year of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|